Ultromics is transforming heart disease detection and treatment using AI to unlock the full potential of echocardiography, empowering clinicians to make more informed decisions to achieve better patient outcomes.

Oxford, UK

Ultromics

The Blue Venture Fund is a corporate venture fund program to which thirty-six BCBS entities have committed over $800 million across four Funds. The Funds invest in promising emerging companies of strategic relevance to Blue Cross and/or Blue Shield Plans and provide access to its portfolio to deploy innovation at scale. The Blue Venture Fund is sponsored by the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield companies.

Companies you'll love to work for